ABSTRACT After 30 min rest in the lying position, 12 healthy male volunteers (average age 22 years) received, in a randomized double-blind cross-over protocol, either saline or naloxone (10 mg iv followed by a continuous infusion of 10 mg/hr). Thereafter they rested for a further 30 min in the recumbent position and for 15 min sitting on a bicycle ergometer; they then exercised to exhaustion. At rest plasma levels of adrenocorticotropin (ACTH), cortisol, and aldosterone increased during infusion of naloxone, while body temperature decreased. During exercise the difference in plasma ACTH between naloxone and saline periods was abolished, while the differences in plasma cortisol and aldosterone lost statistical significance. Intra-arterial pressure, heart rate, ventilation, 02 uptake, and CO2 output were continuously monitored throughout the experiment and were not affected by naloxone. This was also the case for several hormonal and biochemical measurements, including those of plasma renin, angiotensin II, norepinephrine, 13,14-dihydro-15-keto-prostaglandin F2a,, glucose and lactate, and serum insulin and growth hormone. Exercise performance was not changed by naloxone. In conclusion (1) during exhaustive graded exercise of short duration opioidergic inhibition of the pituitary-adrenocortical axis is probably not sustained, (2) apart from the latter mechanism, the present study does not support the hypothesis that endogenous opioids are involved in various hemodynamic, respiratory, and hormonal responses to this type of exercise. Circulation 72, No. 5, 982-990, 1985. THE SENSITIVITY of the human cardiovascular and endocrine systems to exogenous opiates has been recognized for a long time. More recently, the interest in opioid-mediated mechanisms in cardiovascular and neuroendocrine physiology has been revived by the discovery of an endogenous opiate system. Opioid peptides and receptors have been shown to be densely distributed not only in nociceptive anatomic sites, but also in autonomic centers closely involved in cardiorespiratory and hormonal regulation. These localizations include the brainstem, the hypothalamopituitary axis, the sympathetic ganglia, and the adrenal medulla. ' In addition, since the discovery of immunoreactive 
THE SENSITIVITY of the human cardiovascular and endocrine systems to exogenous opiates has been recognized for a long time. More recently, the interest in opioid-mediated mechanisms in cardiovascular and neuroendocrine physiology has been revived by the discovery of an endogenous opiate system. Opioid peptides and receptors have been shown to be densely distributed not only in nociceptive anatomic sites, but also in autonomic centers closely involved in cardiorespiratory and hormonal regulation. These localizations include the brainstem, the hypothalamopituitary axis, the sympathetic ganglia, and the adrenal medulla. ' In addition, since the discovery of immunoreactive /3-endorphin in normal human plasma,2 several investigators have demonstrated that the levels of circulating /3-endorphin3 -and its precursor /3-lipotropin6 are stimulated by both maximal and submaximal exercise and that this increase is related to the intensity of effort4 and is augmented by training. 6 In view of these findings, the present study aimed to investigate in healthy human volunteers the role of opioid mechanisms in various hemodynamic, respiratory, and humoral responses to exercise with the use of naloxone as a pharmacologic probe. Accordingly, throughout this article the term opioid refers to any directly acting endogenous compound, the actions of which are sterospecifically antagonized by naloxone.
Methods
Subjects. Twelve normal male volunteers from 21.7 + 0.4 (SE) years old and weighing at initial examination 69.5 + 1.9 kg gave their informed written consent and participated in the present study. Their mean height was 180 + 2 cm. They remained on a liberal diet. Their 24 hr urinary sodium and potassium excretion averaged 142 + 16 and 72 + 7 mmol, respectively, and remained constant throughout the study.
Experimental protocol. All experiments were performed in an air-conditioned laboratory, where room temperature was sta-bilized between 18°and 220 C. The protocol, which was approved by the Ethical Committee of the Faculty of Medicine (K. U. Leuven), is summarized in figure 1 . The subjects, sitting on a bicycle ergometer, performed graded and uninterrupted exercise tests until exhaustion. A pretest, meant to assess the subjects' maximal exercise capacity, antedated the subsequent experiments on average by 1 month. For this pretest the initial external workload of 10 W was increased by 10 W every minute. Oxygen uptake, carbon dioxide output, and ventilation at the maximal workload were determined and the external workloads, corresponding to incremental steps of 10% of the maximal exercise capacity, were computed.
On the morning of the two subsequent "experimental" tests, which were on average 2 months apart, the subjects had a light breakfast without caffeine-containing beverages. Thereafter they came to the laboratory. After the start of the experimental intervention, the subjects remained recumbent for a further 30 min (RR experimental period). The subjects then assumed the sitting position on the bicycle ergometer for 15 min (RS period). Finally, the exercise test was started at an external workload corresponding to 10% of the maximal exercise capacity determined on the occasion of the pretest. Every 3 min the external workload was augmented by a further 10% of the pretest maximum. The volunteers were asked to continue cycling up to 3 min at 100% of their previously determined maximal exercise capacity, but could stop the two exercise tests earlier if they reached complete exhaustion. The subjects were not informed about the maximal exercise level they attained during any of the tests.
Hemodynamic and respiratory measurements and body temperature. Systolic and diastolic intra-arterial pressure were measured directly through the indwelling catheter in the brachial artery with an electronic transducer (Elema Schonander EMT 34) and recorded continuously on a Mingograph 81 ink-jet recorder. The zero reference point for arterial pressure was kept constant at the midchest level independent of the position of the body. Mean arterial pressure was obtained by electrical damping every 5 min during the RR control and experimental periods and every minute during RS and cycling. Heart rate was determined from the electrocardiogram, which was continuously registered throughout each experiment.
Expired gas was collected in a mixing box by an open-circuit method. Oxygen uptake and carbon dioxide output were continuously calculated from the volume of the expired gas and its 02 and CO2 concentrations, determined by electronic gas analyzers that were calibrated before each experiment with test gases of known composition (Siregnost FD, Siemens 
Results
Pretest. At the pretest the volunteers attained a maximal workload of 298 ± 11 W (mean ± SE). At maximal exercise, peak ventilation, oxygen uptake, and carbon dioxide output averaged 114 ± 5, 3.54 0.10, and 3.82 liters/min, respectively.
Measurements obtained before the injection of saline or naloxone. In the comparison of the two experimental days before the injection of saline or naloxone, no differences were found in body weight (69.6 ± 2.1 vs 69.7 ± 1.9 kg, respectively), temperature (36.64 ± 0.080 vs 36.62 ± 0.100 C), blood pressure (figure 2), heart rate ( 
Discussion
Antagonism by naloxone has been widely used as a pharmacologic tool to disentangle the involvement of opioid mechanism in human physiology at rest. 9-14 In contrast, only few studies have used this drug in the investigation of the hormonal response to physical effort'-'7 or to study exercise performance.'8 A major concern of the present study was therefore to validate its methodology. This goal was achieved by also recording observations at rest and by testing their reproducibility in comparison with previously reported data from the literature.
Findings in subjects at rest. The present study demonstrated that opioid antagonism in subjects at rest in both the supine and sitting positions did not produce significant changes in intra-arterial pressure. This is in agreement with the work of other investigators, 13. 19 who reported that naloxone, although possibly increasing the sensitivity of baroreflex function,'9 does not alter blood pressure in man, either in the supine position or during 6 hr of 70 degree head-up tilt. The hypothesis that opioid mechanisms do not play a key role in the regulation of systemic arterial pressure in healthy resting but awake subjects is furthermore substantiated by the observation that, similar to naloxone most,'9-22 although not all,'3 studies using opioid agonists such as morphine20 or met-enkephalin analogues'3, 21, 22 failed to demonstrate a significant effect on blood pressure.
In agreement with earlier findings, the present study confirmed that opioid antagonism by naloxone in normal resting but awake men does not interfere with heart rate'9 23 24 or respiration,23' 25 whereas body temperature is reduced by the drug. 24 26 Furthermore, in accordance with previous studies conducted in resting human subjects, opioid antagonism by naloxone did not change the serum levels of growth hormone measured under basal resting conditions,9"' but did produce an elevation of the plasma levels of adrenocorticotropin2' '3 and cortisol.8-'13 Thus, results of the present study also support the concept that inhibitory opiate receptors contribute to the modulation of the pituitary release of adrenocorticotropin in resting human subjects. 12' 13 In addition, we found that opioid antagonism increased the plasma aldosterone concentration at rest, while apart from adrenocorticotropin, several other known determinants of adrenal mineralocorticoid secretion were unaffected throughout the study. These determinants included plasma renin and angiotensin II and serum sodium and potassium. The simultaneously occurring increase in the plasma levels of the two adrenal hormones cortisol and aldosterone on treatment with naloxone is therefore likely to be caused by the enhanced adrenocortical stimulation by adrenocorticotropin, although direct interference with a local opiate-mediated inhibitory mechanism in the adrenal gland itself cannot be ruled out on the basis of the present experiments in vivo. 27, 28 Opiate agonists have previously been shown to interfere with carbohydrate metabolism at various levels: they stimulate the pancreatic islet secretion of glucagon and insulin, '4' 29, 30 but may also reduce hepatic glucose production.3' In contrast to these agonist ef- 33 The present study demonstrated an increase in plasma adrenocorticotropin, from which an enhanced release of ,3-endorphin can be inferred36 3, 32, 33 Apparently, during exercise opioid receptors accessible via the systemic circulation are exposed to a higher concentration of 13-endorphin and possibly other endogenous opiate agonists. The most logical approach to the exploration of the involvement of the endogenous neuroendocrine opiate system in the response to exercise was therefore to inhibit the action of the endogenous ligands at the level of their receptor with the use of naloxone as a pharmacologic probe.
Hemodynamic and respiratory responses to exhaustive graded exercise of short duration. The present study demonstrated that during exercise neither the hemodynamic nor the respiratory measurements were significantly different between the two experimental days. To explain this lack of effect, the possibility should be considered that, as exercise progressed, naloxone no longer reached the endogenous opiate receptors in an amount sufficiently large to sustain their inhibition. Naloxone, however, with its extremely rapid penetration into the brain34 and its reported serum half-life of 64 min,34 was infused continuously throughout the experiments. In addition, a further study of similar design in 10 normal volunteers showed that the plasma concentration of naloxone, determined by high-pressure liquid chromatography with electrochemical detection, rose to 43.5 + 4.0 ng/ml (mean + SE) in subjects at rest and was subsequently maintained during exercise, averaging 37.2 + 3.0 and 51. 4 4.3
Vol. 72, No. 5, November 1985 ng/ml at 30% and 60% of peak exercise and 50.9 4.3 ng/ml at the end of cycling.* This is higher than the 5 to 10 ng/ml peak serum concentrations of naloxone obtained within 5 Since plasma norepinephrine levels followed a similar pattern on both experimental days, the present study suggests that the noradrenergic activation induced by physical effort is not modulated by endogenous opiates. Similarly, the exercise-induced activation of carbohydrate metabolism and of glucose utilization do not seem to be influenced by endogenous opiate-mediated mechanisms, since plasma insulin, glucose, and lactate levels remained similar throughout the two tests. The brisk rise in plasma insulin, which occurred at the end of peak exercise, followed the concurrent overshoot of plasma glucose, when suddenly energy demand decreased. Finally, our findings on growth hormone are in agreement with those of Mayer et al.,'5 but at variance with those of other researchers, who reported that naloxone blunted the maximum incremental response of growth hormone to exercise in normal subjects'6 as well as in athletes. '7 
